Answers are grounded in this paper and cite their sources.
Polypharmacy, or the simultaneous use of multiple drugs, is a growing global concern, particularly in aging populations. In Poland, the older adults population is steadily increasing, with over 23 million people having been prescribed medications, averaging 3.7 active substances per prescription. Around 11.7% of the population experiences multidrug use, with the elderly most affected. This raises significant concerns, as polypharmacy can lead to adverse drug reactions, lower medication adherence, and higher healthcare costs. Preventing and managing drug interactions is crucial for patient safety and requires proactive efforts from healthcare professionals. In Poland, challenges include limited communication between providers and the absence of standardized guidelines. To tackle this issue, a multidisciplinary approach involving healthcare providers, policymakers, and researchers is essential. Managing polypharmacy involves various strategies, including medication reviews, prescrip¬tion waivers, and family involvement. Tools such as MUSE and ARMS-P can help assess and improve medication adherence. Additionally, further research is needed to explore how cognitive ability, particularly in conditions like dementia, affects pharmacotherapy outcomes. In conclusion, addressing polypharmacy in Poland requires comprehensive strategies that incorporate various management techniques and consider cognitive factors. Ongoing research is vital to ensure optimal care for the aging population in a rapidly changing healthcare environment.
No takes yet. Share an insight, caveat, or question.
Wojciech Timler (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: